Source:http://linkedlifedata.com/resource/pubmed/id/16464741
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-2-8
|
pubmed:abstractText |
Multiple immune mediators have been mentioned as playing a role in the pathomechanism of type1 DM. Interleukin (IL)-1beta, and tumor necrosis factor (TNF)-alpha play a central role in the autoimmune destruction of pancreatic beta-cells, whereas IL-6 inhibits TNF-alpha secretion, and may have some protecting effects. In our study, we aimed to investigate the association between these three cytokines' single nucleotide polymorphisms (IL-6 gene G(-174)C, TNF-alpha gene G(-308)A and IL-1beta gene C(3954)T polymorphisms) and age-at-onset of type 1 diabetes mellitus (T1DM) in 165 diabetic children (median age: 17 years). Polymorphisms were determined using the PCR-RFLP method. We found that the age-at-onset of T1DM was significantly different in patients with a different IL-6 genotype (median age-at-onset of T1DM was: 8, 6 and 4.5 years in children with the (-174)GG, GC and CC genotypes, respectively; p < 0.01). Adjusted for TNF-alpha and IL-1beta polymorphisms, patients with a IL-6 (-174)CC genotype have a 3.0-fold (95% CI: 1.2-7.1) increased risk of developing diabetes before the age of 6 years than (-174)G allele carrier patients. However, we found this association to be present only in patients who carried the TNF-alpha (-308)A or IL-1beta (3954)T allele, i.e. in patients with high TNF-alpha and high IL-1beta producer genotypes. We suppose that in the case of high TNF-alpha and IL-1beta producer genotypes, elevated proinflammatory cytokine levels result in a higher production of IL-6 in (-174)G allele carrier patients. This elevated IL-6 level may have a protective effect against the development of T1DM and may delay the destruction of pancreatic beta-cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1148-5493
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
277-81
|
pubmed:meshHeading |
pubmed-meshheading:16464741-Age of Onset,
pubmed-meshheading:16464741-Child,
pubmed-meshheading:16464741-Child, Preschool,
pubmed-meshheading:16464741-Diabetes Mellitus, Type 1,
pubmed-meshheading:16464741-Epistasis, Genetic,
pubmed-meshheading:16464741-Female,
pubmed-meshheading:16464741-Genotype,
pubmed-meshheading:16464741-Heterozygote Detection,
pubmed-meshheading:16464741-Humans,
pubmed-meshheading:16464741-Insulin-Secreting Cells,
pubmed-meshheading:16464741-Interleukin-1beta,
pubmed-meshheading:16464741-Interleukin-6,
pubmed-meshheading:16464741-Male,
pubmed-meshheading:16464741-Polymorphism, Single Nucleotide,
pubmed-meshheading:16464741-Regression Analysis,
pubmed-meshheading:16464741-Tumor Necrosis Factor-alpha
|
pubmed:year |
2005
|
pubmed:articleTitle |
Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms.
|
pubmed:affiliation |
Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary. hecsito@axelero.hu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|